REVIEW article

Front. Cell. Infect. Microbiol.

Sec. Clinical Infectious Diseases

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1601688

Coculture of Tumor Organoids with Pathogenic Microorganisms: A Novel System to Mimic in vivo Pathogenic Infection

Provisionally accepted
Xue  ZhangXue Zhang1Shulan  SunShulan Sun1Siqi  ChengSiqi Cheng2Junze  DaiJunze Dai3Furong  DuFurong Du4Jingrui  WangJingrui Wang4Dan  WeiDan Wei5Yichao  YanYichao Yan6Yefu  LiuYefu Liu1*
  • 1Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, China
  • 2China Medical University, Shenyang, Liaoning Province, China
  • 3Dalian Medical University, Dalian, Liaoning, China
  • 4Kingbio Medical Co., Ltd., Chongqing, China
  • 5Liaoning Vocational College of Medicine, Shenyang, China
  • 6International Hospital, Peking University, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

Since the early 20 th century, there has been extensive discussion on the intricate relationship between pathogenic infection and tumors. However, most studies on host-pathogen interactions are performed based on the in-vitro culture, immortalized cell lines or animal experiments. A significant challenge lies in accurately establishing a coculture model between tumors and pathogens under the threedimensional (3D) context. Recently, the hybrid model system that incorporates 3D tumor organoids and two-dimensional cell lines have been gradually used to analyze the intricate relationship between pathogens and tumors, and several coculture techniques for tumor organoids and pathogens have also been developed. Therefore, this study systematically reviewed the preparation and identification of tumor organoids, coculture techniques with pathogens, and their clinical applications, aiming to further understand and simulate the interaction mechanism between the hosts and pathogens.

Keywords: tumor organoids, microorganisms, Pathogenic infection, coculture, interactions

Received: 28 Mar 2025; Accepted: 11 Jun 2025.

Copyright: © 2025 Zhang, Sun, Cheng, Dai, Du, Wang, Wei, Yan and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yefu Liu, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.